# 1. Existing UI State

MyoLab-AI already has a detailed Next.js frontend under `apps/web-portal`. The implementation includes a full AppShell, role-selection login, session workflow, UC1 replay, UC2 assessment, review/report routes, mock services, schemas, UI primitives, and Playwright/Jest tests.

# 2. Architecture Discovered

The app uses Next.js 14 App Router, React 18, TypeScript, CSS Modules, global CSS tokens, lucide icons, React local state/context, and deterministic browser-side mock repositories. API integration is mixed: UC1/UC2/Day24 clients can call HTTP endpoints, while most session workflow pages use `MockWorkflowRepository`.

# 3. What Was Already Strong

UC1 replay is strong: it validates server payloads, fails closed, uses idempotency keys, hides feedback controls for patient role, separates technical confidence from clinical probability, and displays provenance/reason codes.

# 4. Gap Summary

Discovery identified 1 P0, 2 P1, 7 P2, and 2 P3 gaps. After remediation: P0 open = 0, P1 open = 0. Remaining gaps are demo-quality or optional polish.

# 5. P0 Fixes

Fixed visible claim-boundary copy across metadata, login, AppShell, session review/report pages, Day24 review/report panels, use-case copy, and protocol/feedback copy. UI now presents research demo, technical evidence, human review, and not-for-clinical-use language instead of clinical report/conclusion/sign-off claims.

# 6. P1 Fixes

Added `apps/web-portal/e2e/golden-research-session.spec.ts`, a deterministic golden demo E2E covering login, skip link, UC1 replay, QC/activity/fatigue reason codes, provenance hashes, feedback submission, QC evidence, RAW/PROCESSED signal identity, and unsupported MFCV reason. Repaired Day59 stress route/auth assumptions.

# 7. Selected P2 Polish

Added a skip-to-content link in AppShell. Added signal viewer sampling-rate display and visual-decimation disclosure. Corrected MFCV unsupported reason to `ELECTRODE_GEOMETRY_NOT_VERIFIED`.

# 8. Preserved Existing Work

No framework migration, design-system rewrite, component-library replacement, or broad schema rename was performed. Existing UI architecture and deterministic mock workflows were preserved.

# 9. Accessibility

Focus-visible exists, skip link is now present, many controls have accessible names, and the golden E2E verifies keyboard skip-link behavior. Remaining limitations: no axe dependency, no formal screen-reader pass, no full multi-browser matrix.

# 10. Human Factors

The highest-risk visible wording has been corrected. Critical actions now read as research/human-review actions rather than clinical finalization. UC1 still provides the strongest fail-closed and provenance behavior.

# 11. API/Data Integration

Backend integration is MIXED. UC1 is strongest; UC2 falls back to mock silently; Day24 review/report expects API or Playwright route mocks. Most portal state is mock/sessionStorage.

# 12. Signal Visualization

Current signal viewer uses SVG with RAW/PROCESSED separation, time alignment checks, manifest/profile/source refs, mask intervals, min/max decimation, sampling-rate display, and visual-decimation disclosure. It still lacks axes, zoom/pan, tooltip/crosshair, and visual mask overlays.

# 13. Security/Privacy

No dangerous HTML rendering or token storage was found. Mock auth is UX-only. `sessionStorage` stores metadata only, but public demo data should remain de-identified. Raw HTTP error rendering remains a P2 gap for real API integration.

# 14. Performance

Production build succeeds with route first-load JS around 87-103 kB. Day59 Playwright stress smoke passed after 5 evidence-route iterations with final JS heap around 88 MB. No full 100k+ browser signal rendering benchmark was added.

# 15. Tests

Passed:

- `pnpm --dir apps/web-portal type-check`
- `pnpm --dir apps/web-portal build`
- `pnpm --dir apps/web-portal exec jest --runInBand` (17 tests)
- `pnpm --dir apps/web-portal exec playwright test e2e/golden-research-session.spec.ts`
- `pnpm --dir apps/web-portal exec playwright test e2e/day24-review-report-regression.spec.ts e2e/day59-cross-feature.stress.spec.ts`

Playwright was run on port 3101 because port 3100 was already in use.

# 16. Golden Demo

Golden demo status: PASS. The deterministic path does not require internet, private credentials, hospital data, or dataset download.

# 17. Known Limitations

Frontend remains portfolio/research-demo oriented. It is not clinically validated, not for clinical use, and not a medical-device UI. Internal legacy names still contain clinical terms; changing them would be a broader schema/API refactor and was not justified for this pass.

# 18. Final UI Readiness

Final status: `UI_READY_WITH_LIMITATIONS`.
